WallStreetZenWallStreetZen

NASDAQ: CRGX
Cargo Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CRGX

Based on 3 analysts offering 12 month price targets for Cargo Therapeutics Inc.
Min Forecast
$23.00+23.13%
Avg Forecast
$29.67+58.82%
Max Forecast
$34.00+82.01%

Should I buy or sell CRGX stock?

Based on 3 analysts offering ratings for Cargo Therapeutics Inc.
Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CRGX stock forecasts and price targets.

CRGX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2023-12-05
lockedlocked$00.00+00.00%2023-12-05

1 of 1

Forecast return on equity

Is CRGX forecast to generate an efficient return?

Forecast return on assets

Is CRGX forecast to generate an efficient return on assets?

CRGX revenue forecast

What is CRGX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$4.7M
Avg 2 year Forecast
$171.3M
Avg 3 year Forecast
$287.1M

CRGX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRGX$18.68$29.67+58.82%Strong Buy
PRAX$54.80$103.00+87.96%Strong Buy
RGNX$16.19$40.38+149.38%Strong Buy
ARCT$26.55$63.25+138.23%Strong Buy
PLRX$11.81$46.67+295.15%Buy
View Top Biotech Stocks

Cargo Therapeutics Stock Forecast FAQ

Is Cargo Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CRGX) stock is to Strong Buy CRGX stock.

Out of 3 analysts, 3 (100%) are recommending CRGX as a Strong Buy, 0 (0%) are recommending CRGX as a Buy, 0 (0%) are recommending CRGX as a Hold, 0 (0%) are recommending CRGX as a Sell, and 0 (0%) are recommending CRGX as a Strong Sell.

If you're new to stock investing, here's how to buy Cargo Therapeutics stock.

What is CRGX's revenue growth forecast for 2025-2027?

(NASDAQ: CRGX) Cargo Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.96%.

Cargo Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast CRGX's revenue for 2025 to be $183,038,192, with the lowest CRGX revenue forecast at $183,038,192, and the highest CRGX revenue forecast at $183,038,192. On average, 1 Wall Street analysts forecast CRGX's revenue for 2026 to be $6,741,709,916, with the lowest CRGX revenue forecast at $6,741,709,916, and the highest CRGX revenue forecast at $6,741,709,916.

In 2027, CRGX is forecast to generate $11,300,738,599 in revenue, with the lowest revenue forecast at $11,300,738,599 and the highest revenue forecast at $11,300,738,599.

What is CRGX's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: CRGX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CRGX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CRGX price target, the average CRGX price target is $29.67, with the highest CRGX stock price forecast at $34.00 and the lowest CRGX stock price forecast at $23.00.

On average, Wall Street analysts predict that Cargo Therapeutics's share price could reach $29.67 by Mar 22, 2025. The average Cargo Therapeutics stock price prediction forecasts a potential upside of 58.82% from the current CRGX share price of $18.68.

What is CRGX's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: CRGX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.